The extracellular vesicle (EV) and exosome therapeutics forum at BIO Asia-Taiwan 2026 convened cell biology researchers, bioprocess engineers, and commercialization executives to evaluate the clinical maturation of exosome-based medicines. Extracellular vesicles have emerged as a revolutionary therapeutic class capable of transferring complex biological payloads, including mRNA, miRNA, siRNA, and recombinant proteins, directly into recipient cells. … The Cell-Free Revolution: Scaling Exosome Therapeutics for Clinical and Commercial Success Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.